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Abstract
Background Previous studies have shown that routine heated
humidifier (HH) do not provide any benefit during continuous
positive airway pressure (CPAP) titration if there are no signif-
icant naso-pharyngeal symptoms. In clinical practice, nasal
diseases and upper airway symptoms are very common. This
study investigates the effects of HH during CPAP titration in
subjects with or without naso-pharyngeal symptoms.
Methods Fifty-two patients who received polysomnography
with CPAP titration were randomly assigned to HH and non-
HH groups. Their nasal cavity, pharynx, and naso-pharynx
were evaluated before CPAP titration, and a questionnaire on
subjective sensation, including naso-pharyngeal symptoms,
willingness to further use CPAP, and sleep improvement, was
used. Objective (e.g., leak, apnea–hypopnea index (AHI) re-
duction, and optimal CPAP pressure level) and subjective data
were analyzed between the two groups.
Results In subjective sensation, the HH group did not have
any benefit in further willingness to use CPAP and in sleep
improvement, but had improved naso-pharyngeal symptoms
(p00.043). There were no significant differences in leak, AHI
reduction, and optimal CPAP pressure, even in patients with
significant naso-pharyngeal symptoms.
Conclusion Routine use of HH is not necessary during CPAP
titration regardless of naso-pharyngeal symptoms.
Keywords Continuous positive airway pressure (CPAP)
titration . Humidifier . Obstructive sleep apnea–hypopnea
syndrome
Introduction
Obstructive sleep apnea–hypopnea syndrome (OSAHS) is a
common medical condition, with an incidence of 4–7% in
the adult general population [1]. Nasal continuous positive
airway pressure (CPAP) is the mainstay of treatment, and its
effectiveness is well documented [2]. Practical guideline
suggests undergoing attended CPAP titration before home
CPAP therapy [3]. However, CPAP can be associated with
troublesome side effects, including nasal congestion, sore
throat, and dry nose and throat [4–6]. Some reports reveal
that the use of heated humidifier (HH) can alleviate upper
airway symptoms and improve CPAP adherence [7, 8].
The degree of sleep improvement during CPAP titration
may be a crucial factor in determining the subsequent use of
this treatment modality [9–11]. Duong’s study has shown
that using HH during CPAP titration offers no additional
benefit both in acceptance and naso-pharyngeal symptoms.
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However, this study excludes subjects with significant naso-
pharyngeal symptoms [12]. In contrast, several studies re-
veal that using HH from weeks to months can reduce naso-
pharyngeal symptoms [13–15]. In clinical practice, OSAHS
patients have high prevalence of nasal diseases and upper
airway symptoms. The role of HH during CPAP titration is
not clear in enrolled patients with naso-pharyngeal symp-
toms, and there is still no consensus about the use of HH
during CPAP titration. Thus, this study was conducted to
investigate the HH effects during CPAP titration.
Methods
Subjects
Patients newly diagnosed with OSAHS were enrolled.
OSAHS was defined by initial diagnostic polysomnography
with an apnea–hypopnea index (AHI) >15/h. Patients with co-
existing congestive heart failure, central sleep apnea, obesity
hypoventilation, and chronic obstructive airway disease were
excluded. Patients who refused CPAP titration or who could
not complete CPAP titration were also excluded. The institu-
tional review board of Chang Gung Memorial Hospital ap-
proved the study, and all subjects signed inform consent.
Study design
This was a randomized control study. Before CPAP titration,
all subjects were referred to the otorhinolaryngology clinic for
evaluation of the nasal cavity, pharynx, and naso-pharynx. All
patients underwent manual CPAP titration to determine the
optimal CPAP level. They were then randomly assigned to
two groups. One group used HH (H4i, ResMed, Syd-
ney, Australia) during CPAP titration, and the other
group did not use HH but underwent titration with the
same CPAP machine and humidifier devices. The technician
did not provide any information about the humidifier to the
study subjects.
The humidification level was applied according to the
manufacturer’s manual (level 2–3) and adjusted accordingly
based on temperature and water condensation. Subjects
completed questions regarding naso-pharyngeal symptoms
before and after CPAP titration and documented their will-
ingness to use CPAP and feelings of sleep improvement
after titration.
Definition of nasal disease
All of the subjects were evaluated by an otorhinolaryngolo-
gist. Patients with positive nasal symptoms were evaluated
further for blood IgE and allergen test. The diagnostic criteria
of nasal diseases were as follows:
1. Rhino-sinusitis. The symptoms for clinical evaluation in-
cluded major and minor criteria. For acute rhino-sinusitis,
the major criteria included purulent discharge, headache,
facial pain or pressure, nasal congestion, decreased smell-
ing sensation, and fever while the minor criteria included
halitosis, fever, weakness, dental pain, ear fullness and
pain, and cough. For chronic rhino-sinusitis, the bases
were two or more of major criteria or one major and two
minor criteria in a 12-week history [16].
2. Allergic rhinitis. The diagnosis was confirmed with a
positive history and specific allergens or the symptoms
from IgE-mediated inflammation [17].
3. Non-allergic rhinitis. It was defined by chronic nasal
symptoms without concomitant allergic disease as de-
termined by allergen-specific antibody tests [18].
4. Nasal septum deviation. It was defined as a deviation of
more than 4 mm from the midline [19].
Polysomnography and CPAP titration
Standard overnight polysomnography included recorded
electroencephalography, bilateral electrooculograms, sub-
mental electromyogram, electrocardiography, nasal and
oro-nasal airflow (nasal pressure and thermistor), oximetry,
chest and abdominal movements (inductance plethysmogra-
phy), body position, sound intensity, and bilateral tibial
electromyogram. All signals were collected and digitized
on a computerized polysomnography system (N7000
Embla, Broomfield, USA). Sleep stages were scored in 30-
s epochs, using the Rechtschaffen and Kales sleep scoring
criteria [20].
Apnea was defined as the absence of airflow for 10 s.
Obstructive apnea was defined as the absence of airflow in
the presence of rib cage and/or abdominal excursions, while
central apnea was defined as the absence of airflow and rib
cage and abdominal excursions. Hypopnea was considered
for any visible reduction in airflow >50% lasting at least
10 s and associated with either a 3% decrease in arterial
oxyhemoglobin saturation or an appearance of electroen-
cephalogram arousal [21]. The AHI was defined as the
average number of apneas and hypopneas per hour of
sleep.
All patients underwent nasal CPAP titration study in the
sleep laboratory in a separate night. In the CPAP titration
study, manual CPAP titration was done to determine the
optimal CPAP level [22]. A CPAP interface was individual-
ly fitted from a wide range of interfaces to maximize com-
fort and minimize leak. All participants used an AutoSet
Spirit S8 (ResMed, Sydney, Australia) throughout the study.
A technician who supervised the study also prepared the
patients and corrected the mask position and fitting initially.
The lowest CPAP pressure (4 cm H2O) was applied to the
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patients initially and increased when the patients went to
sleep. The optimal CPAP pressure was determined when the
pressure could eliminate apnea, hypopnea, desaturation, and
snoring in a supine position and considered “better” in
rapid-eye movement sleep. Leak values, including median
leak, 95th percentile leak (leak level covering 95% of the
study period), andmaximum leak, were read from the AutoSet
Spirit S8 by the software of AutoScan 5.7 (ResMed, Sydney,
Australia).
Questions for naso-pharyngeal symptoms
and subjective feeling
Patients completed the questions of naso-pharyngeal
symptoms score before and after CPAP titration. Ques-
tions on nasal–pharyngeal symptoms involved five items
(nasal congestion, rhinorrhea, sore throat, and nasal and
mouth dryness) presented via visual analog scale rated
on ten-point scale. There were also questions about
willingness to use CPAP and on sleep improvement
sensation after completing CPAP titration (Fig. 1). Total
upper airway symptom (TUAS) is defined the sum of total
score of nasal congestion, rhinorrhea, sore throat, and nasal
and mouth dryness.
The study also compared optimal CPAP pressure, leak
values, degree of AHI, willingness to further use CPAP, sleep
improvement, and naso-pharyngeal symptoms between the
two groups.
Statistical analysis
Statistical evaluations were performed using the SPSS Soft-
ware (SPSS Inc., Chicago, IL). Data were presented as mean ±
standard deviation (SD). Comparison between leak, AHI re-
duction, optimal CPAP pressure, naso-pharyngeal symptoms,
willingness to use CPAP, and sleep improvement sensation
were done using the Mann–Whitney U test. A p<0.05 was
considered statistically significant.
Results
Of the 57 patients enrolled, five were excluded (two with
extremely high AHI, one with incomplete CPAP titration,
and two who did not complete the questionnaires). The 52
subjects were randomly divided to the HH and non-HH
groups. Their basic characteristics, including important base-
line data such as AHI, body mass index, age, Epworth sleep-
iness score, and gender, were similar (Table 1). The
prevalence of nasal diseases was high. Chronic mucosal dis-
eases, including rhino-sinusitis (n08), allergic rhinitis (n018),
and non-allergic rhinitis (n014), were as high as 77% (n040).
Anatomic diseases like nasal septum deviation also had a high
incidence of 48% (n025). Twenty-three subjects had both
chronic mucosal disease and nasal septum deviation, while
four subjects with combined allergic rhinitis and rhino-
sinusitis. Although the ratio of nasal diseases was high, the
Fig. 1 Questions for
naso-pharyngeal symptoms
and subjective feeling
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prevalences of chronic mucosal disease (p00.55) and nasal
septum deviation (p00.48) between HH and non-HH groups
were similar.
Leak values, including median leak, 95th percentile leak,
and maximum leak, were similar in the two groups (Table 2).
Furthermore, AHI reduction amounts and optimal CPAP pres-
sure were not different between the two groups. In terms of
subjective sensation, willingness to further use CPAP and
feelings of sleep improvement were likewise similar (Table 2).
The TUAS scores were improved in the HH group (p00.043)
(Fig. 2). But individual naso-pharyngeal symptoms were not
statistically different between the two groups.
Discussion
The present study reveals that HH during CPAP titration does
not alter objective parameters such as leak, optimal CPAP
pressure, and AHI reduction. In subjective sensation, HH
use does not change the willingness to further use CPAP or
improves sleep sensation, but it improves naso-pharyngeal
symptoms. Duong’s andWiest’s studies investigated the effect
of HH on CPAP titration, and both studies prove that HH does
not change objective data (i.e., optimal CPAP level and AHI
reduction) [12, 23]. Furthermore, their studies also do not
show that HH improves the acceptance of CPAP use. Wiest’s
study did not evaluate the naso-pharyngeal symptoms of its
subjects [23], while Doung’s study showed that HH does not
improve naso-pharyngeal symptoms [12]. The objective data
of the current study is similar to those of both studies.
There are no differences in optimal pressure level and
AHI reduction between the HH and non-HH groups. How-
ever, the naso-pharyngeal symptoms are improved in the
HH group, and the effects are predominantly in the mouth
and nasal dryness symptoms. The difference may be due to
the different patient selection. Doung’s study excludes sub-
jects with nasal diseases and significant nasal symptoms
whereas the present study has subjects with high prevalence
of nasal diseases and naso-pharyngeal symptoms (nearly
70%). Therefore, the different patient populations may be
the cause of the differing results.
The study by Massie et al. is the first to proposed that HH
improves both compliance and naso-pharyngeal symptoms
[7]. Rakotonnanahary et al. also posited the same results and
revealed that patients with chronic nasal mucosal diseases,
post-uvulopalatopharyngoplasty, old age, and mouth dryness
Table 1 Demographic characteristics
Characteristics Without HH With HH p value
(n026) (n026)
Sex (M/F) 23/3 23/3 1
Age 47.08±11.36 46.50±12.10 0.45
BMI, kg/m2 30.03±3.73 28.77±3.44 0.36
ESS 12.31±5.09 11.81±4.95 0.78
AHI (times/h) 53.74±22.32 56.65±21.55 0.58
NC (cm) 40.35±5.07 40.44±3.33 0.29
Nasal disease 17 19 0.55
Data presented as mean ± SD or number
Abbreviations: HH heated humidifier, BMI body mass index, ESS
Epworth Sleepiness Scale, AHI apnea–hypopnea index, NC neck
circumstance
Table 2 Objective and
subjective parameters between
patients with and without
heated humidifiers
Sleep improvement presented as
subject number; other data pre-
sented as mean±SD or number
Abbreviations: HH heated
humidifier, AHI apnea–hypopnea
index, CPAP continuous positive
airway pressure
Parameters Without HH With HH p value
Objective (n052)
Optimal CPAP pressure (cm H2O) 9.88±2.16 9.56±2.26 0.66
AHI under CPAP 6.11±5.08 8.65±8.37 0.28
Median leak (L/s) 0.056±0.036 0.059±0.069 0.28
95% Leak (L/s) 0.132±0.119 0.185±0.183 0.17
Maximum leak (L/s) 0.445±0.255 0.461±0.304 0.77
Subjective (n052)
Sleep improvement, n (better/similar/worse) 10/13/3 10/11/5 0.74
Willingness of use CPAP 5±2.84 4.88±2.58 0.385
Fig. 2 Total upper airway symptom (TUAS) improvement score is the
mean reduction of naso-pharyngeal symptoms that rated on a ten-point
visual analog scale. Degree of improvement in total naso-pharyngeal
symptoms between subject with and without heated humidifier (p0
0.043). HH heated humidifier
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due to medication achieve greater improvement [8]. Although
several studies do not show the benefit of HH for CPAP
compliance, most studies reveal that HH can improve naso-
pharyngeal symptoms and reduce some side effects of CPAP
[13–15, 24]. The reasons for the inconsistencies are not
known. The diversity of studies involves different study
designs and selection biases of patients. Nonetheless, more
and more studies reveal that routine use of humidifiers does
not alter CPAP compliance. Compliance is influenced by mul-
tiple factors, and the relationship between naso-pharyngeal
symptoms and compliance is not straightforward. Thus, HH
may improve naso-pharyngeal symptoms but does not help
improve compliance.
Richard et al. demonstrated the presence of mouth leaks
during CPAP use, which leads to a rise in nasal resistance that
HH can largely prevent [25]. The authors speculate that mouth
breathing generates unidirectional nasal flow that causes dry-
ness of the nasal mucosa. It induces mucosal congestion that
increases nasal resistance, which in turn also increases the
possibility of mouth breathing and generates a vicious cycle.
Theoretically, HH can prevent increased nasal resistance and
reduce mouth breathing that can further decrease leak. Data
from this study showed that HH does not reduce leak. The
reason is not clear, and there is no study that evaluates the
efficacy of HH on leak. Fischer’s study demonstrated the
humidity level decreased when nasal mask leak developed,
but compared with Richard's study the humidity level did not
significantly decrease [26]. The possible explanation is that
excessive mouth breathing creates a high unidirectional flow
on purpose, as shown in Richard’s study performed in exper-
imental conditions. However, most patients who receive CPAP
therapy do not generate as much flow as Richard’s study and
do not increase nasal resistance asmuch. Therefore, the present
study does not demonstrate that HH reduces leak.
The limitation of this study is the optimal humidity level.
Optimal humidity level is different for each subject because
it is complex and relates to multiple factors, including tem-
perature, air humidity, subjective sensation, and generated
flow and pressure. The humidifier used was set to levels II
to III as recommended by the manufacturer and based on
clinical experience. The temperate of the sleep laboratory
was controlled at 22–26°C. Although this setting might not
generate optimal humidity level for all subjects, most did
not present significant water condensation, and there were
some vapors in the mask. There is a new model of humid-
ifier that can automatically control humidity level, and some
have been associated with heated tube to prevent water
condensation. However, this type of new humidifier was
not available during the study period. Further investigation
is needed to evaluate whether auto-control humidifiers have
better efficacy than conventional humidifiers. Another lim-
itation is relatively small sample size might result in the low
statistical power.
In conclusion, the regular use of HH, regardless of sig-
nificant naso-pharyngeal symptoms, does not provide any
benefits of AHI reduction, optimal CPAP level, and further
CPAP acceptance. While HH improves naso-pharyngeal
symptoms, its use during CPAP titration have several dis-
advantages, including water condensation, high noise
due to water dropping in the expiration pore, cleaning
of humidifier devices, and changing water for each patient.
Therefore, regular use of HH during CPAP titration is not
recommended.
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